Studies On Macrocyclic Lactone Antibiotics Xi. Anti-Mitotic And Anti-Tubulin Activity Of New Antitumor Antibiotics, Rhizoxin And Its Homologues

119Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The mode of action of rhizoxin (la), a new antitumor macrolide, was investigated. Rhizoxin inhibited fusion of the male and the female pronuclei in fertilized sea urchin eggs and inhibited cilia formation in the deciliated sea urchin embryos. In vitro, polymerization of tubulin isolated from porcine brains was completely inhibited at a 1 x 10~5 m concentration of rhizoxin, and tubulin which had been polymerized by incubation at 37°C for 30 minutes was depolymerized by addition of 1 x 10-5m of the drug. Activity of rhizoxin against tubulin polymerization was compared with those of other anti-tubulin drugs such as colchicine, vinblastine and ansamitocin P-3. The homologues of rhizoxin, 1b~3b, also inhibited polymerization of the purified microtuble protein at almost the same extent as rhizoxin. © 1987, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Takahashi, M., Iwasaki, S., Kobayashi, H., Okuda, S., Murai, T., Sato, Y., … Nagano, H. (1987). Studies On Macrocyclic Lactone Antibiotics Xi. Anti-Mitotic And Anti-Tubulin Activity Of New Antitumor Antibiotics, Rhizoxin And Its Homologues. The Journal of Antibiotics, 40(1), 66–72. https://doi.org/10.7164/antibiotics.40.66

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free